The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs

By M. Bennett. Pain, 2001

1,008 citations recorded by the source corpus.

Subfields: Neurology, Pharmacology, Physiology

View Paper: https://www.semanticscholar.org/paper/6a73fa500d64919007a809d30c45a61a32a74814

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Neurology

1. M. Lanteri-Minet
2. Steven P. Cohen
3. D. Bouhassira
4. N. Attal

In Pharmacology

1. M. Lanteri-Minet
2. Steven P. Cohen
3. D. Bouhassira
4. N. Attal

In Physiology

1. M. Lanteri-Minet
2. Steven P. Cohen
3. D. Bouhassira
4. N. Attal

Citations in the corpus

• Prevalence of chronic pain with neuropathic characteristics in the general population (2008, neutral): “Like other symptom-based screening tools validated recently (Bennett, 2001; Krause and Backonja, 2003; Portenoy, 2006; Freynhagen et al., 2006a), the DN4 questionnaire has very good discriminative properties for the identification of neuropathic pain characteristics.”
• Development and validation of the Neuropathic Pain Symptom Inventory (2004, methodology): “More recently, the LANSS Pain Scale (Bennett, 2001) and the Neuropathic Pain Questionnaire (Krause and Backonja, 2003) have been developed for the diagnosis of neuropathic pain rather than for their evaluation.”
• Epidemiology, diagnosis, and treatment of neck pain. (2015, background): “Copyright © and Signs) pain scale.(18,19) For chronic low back pain, multiple studies have indicated a prevalence range of between 17% and 55% for predominantly neuropathic pain in a variety of cohorts, with a median of 41%.”